oral glp-1 medications Medication Helps Patients Maintain Weight Loss | Newsroom Novo Nordisk's oral GLP-1 drug

Those with a BMI Over 30 Generally, these medications are reserved for individuals with a Body Mass Index (BMI) of 30 or greater, or 27 or greater with a weight-related health condition like high blood pressure or type 2 diabetes

Despite effectiveness, side effects like nausea and diarrhea are common, and most Americans say they dont plan to take them

What began as treatments for diabetes and obesity has rapidly expanded into prevention of cardiovascular disease, slowing kidney decline, tackling liver disease, and even tentative explorations into neurodegeneration

Your clinician will manage titrationslowly adjusting your medication to find the right doseand provide practical strategies to prevent or manage side effects

Wegovy, Zepbound, Ozempic are names that have moved from prescription pads into everyday conversation, appearing in news headlines, social media feeds, and dinner table discussions with a speed that reflects just how much cultural weight we collectively attach to the question of body size

If tirzepatide is your medication of choice, that dedicated guide provides more granular information than this overview